NovaBridge Biosciences NBP
NASDAQ NBP
$0.86 +0.00 (+0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

NovaBridge Biosciences (NBP) Other Non-Current Liabilities (2018 - 2026)

Updated

NovaBridge Biosciences (NBP) reported Other Liabilities of $1.33 million for Q2 2026.

Analysis

NovaBridge Biosciences (NBP) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2025, NovaBridge Biosciences posted Other Liabilities of $511,000.

  • Other Liabilities has a five-year compound annual growth rate of -18.0% (FY2020 to FY2025).
  • By year, Other Liabilities came in at $106,000 in FY2023 (-95.7%), $2.46 million in FY2022 (+5.0%) and $2.34 million in FY2021 (+70.4%).
  • The Q2 2026 figure ranks as the highest quarterly Other Liabilities since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 NovaBridge Biosciences 99.23 Mn -696.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.33 Mn
Dec 31, 2025 511,000.00
Dec 31, 2023 9.80 Mn
Jun 30, 2023 6.76 Mn
Dec 31, 2022 2.44 Mn
Jun 30, 2022 2.08 Mn
Dec 31, 2021 2.34 Mn
Jun 30, 2021 960,000.00
Dec 31, 2020 1.38 Mn
Sep 30, 2020 1.24 Mn
Jun 30, 2020 1.33 Mn
Dec 31, 2019 39.16 Mn
Dec 31, 2018 816,902.25
API Access

NovaBridge Biosciences Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=NBP&period=max&api_key=YOUR_API_KEY